Journal
CANCER CELL
Volume 25, Issue 2, Pages 135-136Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2014.01.026
Keywords
-
Categories
Funding
- Cancer Research UK [C6228/A12512, C37059/A11941, C6228/A5433] Funding Source: Medline
Ask authors/readers for more resources
Therapeutic decisions for muscle-invasive bladder cancer (MIBC) are largely based on histopathologic characteristics. In this issue of Cancer Cell, Choi and colleagues report three molecular subtypes of MIBC with the potential to guide prognosis, patient stratification, and treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
